A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.

The NASA astronaut was stuck in space for over 9 months (286 days appoximately). Although she is back on Earth, her body is ...

Bone Density Loss: Prolonged exposure to microgravity can also lead to decreased bone density, increasing the risk of fractures. Research indicates that astronauts can lose around 1% of their bone ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

US astronauts Butch Wilmore and Suni Williams are finally coming home — here are some of the health issues they may ...

Apitegromab is an investigational treatment aimed at improving motor function for people living with spinal muscular atrophy. Scholar Rock said it has also submitted and received validation for its ...

The Delhi High Court on Monday dismissed an interim injunction application filed by Swiss pharmaceutical giant F Hoffmann-La ...

The realm of outer space has long fascinated humanity, but it also holds significant challenges, especially concerning human health. Recently, the return of two astronauts who spent nine months in ...

The challenge of the obesity epidemic is widespread and one that even pediatricians face constantly,” a Connecticut doctor ...